Retrospective Study Reveals Unexpected, Promising Findings: Accepted For Publication In Journal Of Geriatric Cardiology

Share Article

Age management medicine leader Cenegenics® Medical Institute announces surprising findings from data analysis of physician-supervised nutrition/exercise/testosterone replacement program, shows reduction in cardio risk factors

Cenegenics Las Vegas

Cenegenics® Medical Institute: Global leader in age management medicine

This study shows we can markedly reduce risk factors for the development of chronic illness, such as atherosclerosis . . . and that it takes more than a wellness program to optimize health.

A retrospective data analysis study of Cenegenics’ nutrition/exercise program with testosterone replacement therapy reveals unexpected findings, greatly reducing cardiovascular risk factors, announced Cenegenics® Medical Institute. The study—a collaborative effort with Dr. Ernst R. von Schwarz, a professor of medicine at UCLA’s David Geffen School of Medicine—has been accepted for publication by the Journal of Geriatric Cardiology.

Investigators assessed the outcome of Cenegenics’ commercially available physician-supervised program on middle-aged, obese male Cenegenics patients who had a clinically proven androgen deficiency and a median age of 52 (± 7.8 years). None of the participants had diabetes, hypertension or cardiovascular disease. Over the 6- to 18-month follow up, participants showed a significant reduction in weight and body fat, but also fasting glucose levels, lipids and total cholesterol levels—key risk factors for cardiovascular disease.

“This is the first reporting—a retrospective data analysis—demonstrating the beneficial effects of a combined, commercially available nutrition/exercise program with testosterone replacement in men who had a clinical indication. Although it is not a randomized controlled prospective study, the findings from this non-randomized study revealed highly significant changes. Further controlled prospective studies should be performed to confirm this initial data,” Schwarz said.

The physician-supervised program encompassed low-glycemic nutrition, interval training and weight training as well as testosterone therapy, with no adverse effects. The statistically significant findings are prompting Cenegenics to consider broadening their parameters, reaching out to high-risk patients who aren’t ill yet, but who could benefit from their risk-reduction program.

“This study shows we can markedly reduce risk factors for the development of chronic illness, such as atherosclerosis . . . and that it takes more than a wellness program to optimize health. From its 1997 beginnings, Cenegenics’ medical system has been based on balance—nutrition/nutraceuticals, exercise and hormone optimization as well as ongoing physician follow-ups. We’re in the business of taking medicine to new directions and heights, not waiting for people to get sick before they’re treated. Our 14-year experience shows the Cenegenics program makes a difference,” Dr. Robert D. Willix, Jr. said.

Willix is Cenegenics’ Chief Medical Officer and CEO/Chief Medical Officer of Cenegenics Boca Raton.

Physicians can learn more about age management medicine directly by calling Cenegenics: Dr. Michael Resnick at 702.953.1574 or Dr. Tim Patel at 702.953.1577.

Visit Cenegenics’ Facebook Fan page, follow them on Twitter and get patient celebrity blogs, health tips and news on their portal site, CenegenicsPost.

For more information about Cenegenics, please visit them online, where you can register for quick access to the online Cenegenics Healthy Aging Kit: informative Guide to Healthy Aging, Executive Summary and media excerpts.

For more information about Cenegenics’ highly regarded, CME-accredited Physician Training & Certification in Age Management Medicine, please visit their nonprofit Cenegenics Education and Research Foundation site.

To schedule an interview, please contact Ann Castro, Cenegenics Director of Media Relations: 702.953.1588.

About Ernst R. von Schwarz, MD, PhD, FESC, FACC, FSCAI
Dr. Ernst R. von Schwarz is board certified in internal medicine by the American Board of Internal Medicine and in cardiology/cardiovascular diseases by the American Board of Internal Medicine. He is a noted professor of medicine at UCLA’s David Geffen School of Medicine. As a clinician and scientist, Schwarz has written more than 100 articles for peer-reviewed publications and has written 10 book chapters on cardiovascular medicine.

About Cenegenics
Cenegenics® Medical Institute, recognized leading authority in age management medicine, has two centers in Las Vegas, Nevada, as well as centers in Charleston, South Carolina; Boca Raton, Florida; Dallas, Texas; Arlington, Texas; Atlanta, Georgia; Chicago, Illinois; Beverly Hills, California; Philadelphia, Pennsylvania; Washington, DC; New York City, NY; Tulsa, OK; Jacksonville, FL; Atlantic City, NJ; Houston,TX; Denver, CO; Scottsdale, AZ. Additional centers are scheduled to open in other major metropolitan areas in the near future. With an established presence in the medical community, Cenegenics uses a proactive approach based on solid science and comprehensive evaluation. Their established protocols have been recognized as the next generation of medical science, capturing global attention. Cenegenics offers CME-accredited physician training and certification opportunities in age management medicine via the nonprofit Cenegenics Education and Research Foundation (CERF). Headquartered in Las Vegas, Cenegenics serves more than 20,000 patients worldwide—2,000 are physicians and their families.

Media contact:
Ann Castro, Director of Media Relations
Cenegenics Medical Institute


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ann Castro, Director of Media Relations
Visit website